MERRIMACK PHARMACEUTICALS IN shareholders Q2 2023

MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 63 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.4%.

MERRIMACK PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
Western Standard LLC 1,672,463$20,571,29517.72%
Newtyn Management, LLC 1,873,694$23,046,4365.44%
Madison Avenue Partners, LP 553,085$6,802,9461.48%
WITTENBERG INVESTMENT MANAGEMENT, INC. 204,994$2,5210.91%
Sio Capital Management, LLC 290,749$3,576,2130.91%
Sepio Capital, LP 294,545$3,622,9040.29%
Yakira Capital Management, Inc. 64,118$788,6510.21%
Nantahala Capital Management 111,148$1,367,1200.13%
FIFTH LANE CAPITAL, LP 10,929$134,4270.04%
KENNEDY CAPITAL MANAGEMENT LLC 91,506$1,125,5240.03%
Mascoma Wealth Management LLC 5,000$61,1000.02%
BOOTHBAY FUND MANAGEMENT, LLC 46,437$571,1750.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 34,200$420,6600.01%
Dorsey Wright & Associates 2,000$24,6000.01%
Tower Research Capital LLC (TRC) 10,567$129,9740.00%
Rise Advisors, LLC 272$3,3400.00%
WEBSTER BANK, N. A. 1,527$18,7820.00%
DIMENSIONAL FUND ADVISORS LP 459,960$5,657,5080.00%
MARSHALL WACE, LLP 87,037$1,070,5550.00%
MetLife Investment Management, LLC 5,610$69,0030.00%
External links

This page lists MERRIMACK PHARMACEUTICALS IN's shareholders in Q2 2023. To view MERRIMACK PHARMACEUTICALS IN's shareholder history, click here.